Zelixir Biotech

Shanghai-based Zelixir Biotech, a leading provider of protein structure prediction and design services, has reportedly secured more than RMB 100 million (USD 14.1 million) in a Series A financing round. The funding was led by Qingdao Qingchi Venture Capital Fund, with additional investments from HM Capital, Hongfeng Investment, and Q…